Related Experiment Videos
Stereoacuity testing in patients with retinal and optic nerve disorders
M B Shah1, G A Fishman, K R Alexander
1Department of Ophthalmology and Visual Sciences, UIC Eye Center, University of Illinois at Chicago, College of Medicine III., USA.
Documenta Ophthalmologica. Advances in Ophthalmology
|January 1, 1995
Summary
This study found that patients with retinal or optic nerve disease often show abnormal stereoacuity on clinical tests. Visual acuity of 20/30 or worse in one eye frequently indicates impaired stereoacuity performance.
Area of Science:
- Ophthalmology
- Neuroscience
- Vision Science
Background:
- Limited comparative data exists on stereoacuity test sensitivity for retinal/optic nerve disease.
- The differential impact of retinal versus optic nerve disorders on stereoacuity is unclear.
Purpose of the Study:
- Compare the relative sensitivity of clinical stereoacuity tests.
- Investigate the impact of retinal and optic nerve diseases on stereoacuity.
- Determine visual acuity thresholds for stereoacuity impairment.
Main Methods:
- Evaluated 42 patients with retinal/optic nerve disorders and 18 controls.
- Utilized Titmus Stereoacuity Test (TST), Randot Stereoacuity Test (RST), and TNO Stereoacuity Test (TNO).
- Compared patient performance to controls and a TST nomogram.
Main Results:
- Abnormal stereoacuity on one test generally predicted abnormality on others.
- No significant difference in TST performance between retinal and optic nerve disease groups.
- Visual acuity of 20/30 or worse in one eye often correlated with abnormal stereoacuity.
Conclusions:
- Clinical stereoacuity tests show consistent abnormalities in patients with retinal/optic nerve disease.
- Retinal and optic nerve diseases have a comparable impact on TST performance.
- Reduced visual acuity is a key indicator for potential stereoacuity deficits.